California Public Employees Retirement System’s Mersana Therapeutics MRSN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-4,328
Closed -$1.75M 2390
2021
Q1
$1.75M Sell
4,328
-517
-11% -$251K ﹤0.01% 2102
2020
Q4
$3.22M Sell
4,845
-92
-2% -$51.2K ﹤0.01% 1694
2020
Q3
$2.3M Buy
4,937
+829
+20% +$419K ﹤0.01% 1755
2020
Q2
$2.4M Buy
4,108
+3,080
+300% +$1.05M ﹤0.01% 1685
2020
Q1
$150K Hold
1,028
﹤0.01% 2970
2019
Q4
$147K Buy
+1,028
New +$75.2K ﹤0.01% 3201

Other funds holding MRSN

California Public Employees Retirement System's MRSN Position: Q2 2021 in Review

California Public Employees Retirement System sold out of Mersana Therapeutics (MRSN) in Q2 2021, closing a stake of 4,328 shares — an estimated $1.75M sold.

California Public Employees Retirement System first reported a position in MRSN in Q4 2019 and held it in 6 quarters. The position peaked at $3.22M in Q4 2020. 131 funds tracked by Wall St. Rank hold MRSN as of Q2 2021.

  • California Public Employees Retirement System reported no remaining Mersana Therapeutics position as of Q2 2021 after selling out during the quarter.
  • California Public Employees Retirement System sold 4,328 Mersana Therapeutics shares in Q2 2021, an estimated $1.75M.
  • California Public Employees Retirement System first reported a position in Mersana Therapeutics in Q4 2019 and held it in 6 quarters.
  • California Public Employees Retirement System's Mersana Therapeutics position peaked at $3.22M in Q4 2020.
  • 131 funds tracked by Wall St. Rank held Mersana Therapeutics as of Q2 2021.

Based on California Public Employees Retirement System's 13F filing for Q2 2021, filed 13 Aug 2021.